Semler Scientific Inc (SMLR) - Total Liabilities

Latest as of September 2025: $136.93 Million USD

Based on the latest financial reports, Semler Scientific Inc (SMLR) has total liabilities worth $136.93 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Semler Scientific Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how Semler Scientific Inc's total liabilities have evolved over time, based on quarterly financial data. See Semler Scientific Inc (SMLR) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Semler Scientific Inc Competitors by Total Liabilities

The table below lists competitors of Semler Scientific Inc ranked by their total liabilities.

Company Country Total Liabilities
Chemclin Diagnostics Co. Ltd. A
SHG:688468
China CN¥344.10 Million
Zhejiang Shengda Pharm
SHG:603079
China CN¥561.97 Million
Hangzhou Coco Healthcare Products Co.Ltd.
SHE:301009
China CN¥739.23 Million
The Star Entertainment Group Limited
F:EE9
Germany €1.07 Billion
Metro Mining Ltd
AU:MMI
Australia AU$174.50 Million
ON24 Inc
NYSE:ONTF
USA $88.91 Million
EDREAMS ODIGEO UNS.ADR/10
F:K0I
Germany €860.06 Million
SES AI Corp
NYSE:SES
USA $50.27 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Semler Scientific Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Semler Scientific Inc (SMLR) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.97 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.30 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.23 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Semler Scientific Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Semler Scientific Inc (2011–2024)

The table below shows the annual total liabilities of Semler Scientific Inc from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 $9.08 Million +44.78%
2023-12-31 $6.27 Million -10.65%
2022-12-31 $7.02 Million +36.92%
2021-12-31 $5.12 Million +5.76%
2020-12-31 $4.85 Million -7.06%
2019-12-31 $5.21 Million +48.00%
2018-12-31 $3.52 Million -48.35%
2017-12-31 $6.82 Million +13.85%
2016-12-31 $5.99 Million +44.33%
2015-12-31 $4.15 Million +2.14%
2014-12-31 $4.06 Million +101.29%
2013-12-31 $2.02 Million -60.03%
2012-12-31 $5.05 Million +341.91%
2011-12-31 $1.14 Million --

About Semler Scientific Inc

NASDAQ:SMLR USA Medical Devices
Market Cap
$5.38 Billion
Market Cap Rank
#14223 Global
#3347 in USA
Share Price
$355.43
Change (1 day)
+0.18%
52-Week Range
$15.21 - $355.43
All Time High
$355.43
About

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardi… Read more